1. For emergency use the Director General of the Directorate General for Health and Consumer Protection shall be authorised to make arrangements with Onderstepoort laboratory in South Africa for the purchase of 750000 doses of monovalent bluetongue vaccine (serotype 2).
2. The arrangements referred to in paragraph 1 shall include the storage of vaccines and airfreight in such a manner that they can be dispatched without delay to the Member States concerned.